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Neudesin (also known as neuron derived neurotrophic factor, Nenf) is a scarcely studied
putative non-canonical neurotrophic factor. In order to understand its function in the
brain, we performed an extensive behavioral characterization (motor, emotional, and
cognitive dimensions) of neudesin-null mice. The absence of neudesin leads to an anxious-
like behavior as assessed in the elevated plus maze (EPM), light/dark box (LDB) and
novelty suppressed feeding (NSF) tests, but not in the acoustic startle (AS) test. This
anxious phenotype is associated with reduced dopaminergic input and impoverished
dendritic arborizations in the dentate gyrus granule neurons of the ventral hippocampus.
Interestingly, shorter dendrites are also observed in the bed nucleus of the stria terminalis
(BNST) of neudesin-null mice. These findings lead us to suggest that neudesin is a novel
relevant player in the maintenance of the anxiety circuitry.
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INTRODUCTION
Neudesin (also known as neuron derived neurotrophic factor,
Nenf) is a 21 kiloDalton secreted protein with 171 aminoacids
(Kimura et al., 2005). Neudesin was classified as a member of
the membrane-associated progesterone receptor family since its
primary structure contains a cytochrome b5-heme/steroid bind-
ing domain (Kimura et al., 2012). Studies in mice showed that
neudesin is most abundantly expressed in the brain and spinal
cord (Kimura et al., 2005). While in the developing mouse brain
neudesin is predominantly expressed in neurons with scattered
presence in other cell types, in the adult brain its expression
seems to be restricted to neurons (Kimura et al., 2005). Neudesin
expression starts at approximately embryonic day 12.5 (E12.5),
as evaluated by real time PCR (RT-PCR) in neural precursor
cells; its expression increases during the rest of the embryonic
period in inverse correlation with the expression of markers of
dividing neural precursor cells (nestin) and in direct correlation
with that of microtubule-associated protein 2 (MAP-2) (a marker
for mature neurons) (Kimura et al., 2005). Of notice, neudesin
expression is higher in the cortical preplate, an area that partici-
pates in the formation of the cerebral cortex. During embryonic
and postnatal development, neurotrophic factors main func-
tions are to provide survival and differentiation of nervous cells
through activation of the p75 and tyrosine kinase (Trk) recep-
tors and by downstream pathways such as MAP and PI-3 kinases
(Russell and Duman, 2002). In adulthood, these downstream cas-
cades activate different functional responses such as axon growth,
dendrite pruning, cell fate decisions (Gray et al., 2013), as well
as the modulation of neurotransmitters, thus regulating synap-
tic plasticity (McAllister, 2001). Importantly, studies in primary
cultures of neurons revealed that neudesin display a neurotrophic
activity. Specifically, neudesin was shown to induce the prolif-
eration of cortical neural precursor cells early in development,
and their subsequent differentiation into neurons (Kimura et al.,
2005, 2006). Nevertheless, the identification of a receptor for
neudesin is still elusive. Even less information is available on the
exact function of neudesin in the adult brain, but in vitro exper-
iments indicate that it may promote the maintenance of neurons
in an autocrine/paracrine mode (Kimura et al., 2005). This neu-
rotrophic activity has been shown to depend on the attachment
of hemin to its cytochrome b5-heme/steroid domain, while a
similar relevant action on the binding of steroids failed to be
demonstrated (Kimura et al., 2008).
The importance of neurotrophic factors in brain maturation
and function was extensively demonstrated (Snider, 1994).
Furthermore, it is well-known that neurotrophic factors such as
brain derived neurotrophic factor (BDNF) and fibroblast growth
factor (FGF) play an important role in the etiology of mood
disorders, such as depression, and in modulating emotional
responses, including anxiety (Masi and Brovedani, 2011; Turner
et al., 2012). In accordance, the limbic brain regions known
to be involved in the modulation of emotional responses, that
include the ventral hippocampus, amygdala and the bed nucleus
of the stria terminalis (BNST), were shown to present an altered
neurotrophins levels after an exposure to harmful stimuli,
such as chronic stress, thus culminating in neurotransmission
imbalance and in synaptic plasticity impairment (Taylor et al.,
2011; Jung et al., 2012). Noteworthy, altered monoamin-
ergic neurotransmission was found in BDNF-null mice
(Ren-Patterson et al., 2005).
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Given the in vitro available evidence on the potential neu-
rotrophic properties of neudesin, in this study we addressed
the role of Nenf in modulating behavior (emotional and cog-
nitive) brain cytoarchitecture and neurotransmission (namely
monoaminergic), for which we used neudesin-null mice.
MATERIALS AND METHODS
ANIMALS
A mouse strain with targeted deletion of the Nenf gene, pro-
vided by Merck-Serono under a material transfer agreement, was
used. The neudesin-null (Nenf−/−) mouse strain was generated
by using a 129/SvEv genomic library from a BAC clone and
the target construct was made by deletion of the entire coding
sequence of the neudesin gene (exons 1–4, ∼12KB) and replac-
ing it by a LacZ-neomicin cassette. The BAC targeting vector was
then inserted into embryonic stem cells (FiH4 ES cells), where
the homologous pieces of DNA were recombined. The cells iden-
tified as homologous recombinant clones were microinjected into
C57BL/6F1 blastocysts to generate chimeric mouse. Initial geno-
typing was performed using a loss-of-native-allele assay. Animals
used in this study were backcrossed in a C57BL/6F background.
Nenf−/− and Nenf+/+ were obtained by crossing heterozygous
animals. Mice genotype was confirmed by PCR using two inde-
pendent sets of primers: one for the LacZ cassette, specific for the
genotype: LacZ-foward 5′-GGTAAACTGGCTCGGATTAGGG-3′
and LacZ-reverse 5′-TTGACTGTAGCGGCTGATGTTG-3′; and
another for the Nenf gene, specific for Nenf+/+ animals:
Nenf-intron3 5′- CTTGGAGTTTGGGGCTGATA-3′, Nenf-exon4
5′-TGGCTTTGTACACCTTGCTG-3′. The amplified fragments
were of 210 and 176 bp, respectively, and distinguishable by elec-
trophoresis through a 1.5% agarose gel. Confirmation of loss of
neudesin synthesis in Nenf−/− was also obtained by perform-
ing immunohistochemistry with a neudesin-specific antibody
(Sigma, St. Louis, USA) in brain samples of both control and
neudesin-null mice; neuronal expression of neudesin was not
detected in neudesin-null mice.
Neudesin-null homozygous mice are viable, fertile, grow
normally and do not display apparent morphological alter-
ations. Adult animals, at the beginning of behavioral analysis
no differences in body weight between littermate controls and
neudesin-null mice were found (Nenf+/+ = 21.13 ± 1.98 vs.
Nenf−/− = 21.28 ± 2.08 g).
Animals were maintained under 12 h light/dark cycles at
22 ± 1◦C, 55% humidity and fed with regular rodent’s chow and
tap water ad libitum. This study was approved by the Portuguese
national authority for animal experimentation, Direcção Geral
de Veterinária (permission ID: DGV9457). All experiments were
performed in accordance with the guidelines for the care and
handling of laboratory animals, as described in the Directive
2010/63/EU of the European Parliament and of the Council.
ADULT BEHAVIOR
Adult behavior was assessed in 3months-oldmalemice, in 3 inde-
pendent sets of animals, of which one is presented here. Eight
neudesin-null and 10 littermates control animals were analyzed
in the open field (OF), elevated plus maze (EPM), forced swim
test (FST) and Morris water maze (MWM) tests, performed by
this sequential order, as an initial behavioral characterization. A
24 h time interval was used between OF, EPM, and FST tests;
a 96 h time interval was used between FST and MWM. After
the first behavioral characterization, the acoustic startle (AS),
light/dark box (LDB) and novelty suppress feeding (NSF) tests
were performed, by this sequence, in order to further evaluate the
anxious-like behavior (see results section below); for this addi-
tional evaluation, another 3 independent sets of animals were
analyzed, and one representative set of 10 neudesin-null males
and 10 control littermate mice is presented here.
Adult behavior tests were performed in all animals during the
light phase of the light/dark cycle at the same period of the day to
avoid physiological differences related to the circadian cycle. The
tests were performed as described next:
Open field
Animals were placed in a room adjacent to the experimental room
1 h before the test. Locomotor activity was assessed in a brightly
illuminated square arena with 43.2 × 43.2 cm size surrounded
by walls to prevent escape. Animals were placed in the center
of the arena and allowed to explore it for 5min. Data collected
through the infrared system (MedAssociates Inc., St Albans, VT)
contained total distance travelled, and distance and time spent in
the center vs. the periphery of the arena.
Forced swim test
Animal learned helplessness behavior was analyzed using the FST
in 2 consecutive days. Mice were placed for 5min in a glass cylin-
der filled with water (24◦C) at a depth of 30 cm. Twenty-four
hours later mice repeated the test in the same conditions (Porsolt
et al., 1977). Trials were video recorded and manually analyzed
using the Etholog V2.2 software (Ottoni, 2000). The 5min of
the second day were analyzed. Data collected consisted in the
duration of swimming and of immobility time.
Morris water maze
MWM was used to evaluate mice spatial reference memory. In
this test, animals were placed in a circular white pool (170 cm in
diameter and 50 cm in height) filled with tap water (24 ± 1◦C)
placed in a poorly lit room. The pool was divided in 4 imaginary
quadrants and a transparent plexiglas platform (14 cm in diame-
ter) was hidden 0.5 cm bellow surface in the center of one of the
quadrants. For each quadrant, external clues were placed in the
walls of the room. The test consisted of 4 trials per day for 4 con-
secutive days. In each trial, animals were randomly placed in each
one of the quadrants and were allowed to swim for 120 s. Mice
that failed to reach the platformwithin this time-period were gen-
tly guided to the platform. The distance and time animals took to
find the platform were recorded using a video camera connected
to a video-tracking system (Videotrack, Viewpoint, Champagne
au Mont d’Or, France).
In the fifth day animals performed the probe and reversal tests.
The probe test consisted of a unique trial without the platform
where the animals were allowed to swim for 120 s. Time and dis-
tance swum in each quadrant were collected and analyzed for the
first 60 s. To test memory flexibility we performed the reversal test,
which consisted in changing the initial position of the platform to
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the opposite quadrant of the pool. Animals were given 3 trials of
120 s each to learn the new position. The percentage of distance
swum in each quadrant is represented.
Elevated plus maze
Anxious behavior was assessed using an apparatus composed of
two opposite brightly illuminated open arms (51 × 10 cm) and
two opposite dark closed arms (51 × 10 × 40 cm) and a central
platform, 74 cm above the floor (NIR plus maze, MedAssociates
Inc.). Animals were placed in the center of the maze and allowed
to explore it for 5min. Data collected consisted of the number of
entries (four paws) in each arm as well as the time spent in each
arm (MedPCIV, MedAssociates software).
Acoustic startle
Startle reflex was measured in a startle response apparatus
(SR-LAB, San Diego Instruments, San Diego, CA, USA), consist-
ing of a non-restrictive plexiglas cylinder (inner diameter 2.8 cm,
length 8.9 cm), mounted on a plexiglas platform and placed in a
ventilated sound-attenuated chamber. Animals were habituated
to the apparatus (5min) 1 day before actual testing. Cylinder
movements were detected and measured by a piezoelectric ele-
mentmounted under each cylinder. A dynamic calibration system
(San Diego Instruments, San Diego, CA, USA) was used to ensure
comparable startle magnitudes. Startle stimuli were presented
through a high frequency speaker located 33 cm above the star-
tle chamber. Startle magnitudes were sampled every ms over a
period of 200ms, beginning with the onset of the startle stimulus.
A startle response is defined as the peak response during 200ms
recording period. A higher startle reflex reflects an increased
anxious state of the animal.
Light/dark box
For this test the OF arena was divided in half. One part was open
and the other consisted of a black plexiglas with an entrance at the
center of the arena facing the bright side. Each animal was placed
alone at the center of the arena facing the lateral wall and allowed
to explore it for 10min. An infrared system (MedAssociates Inc)
registered the time spent in each compartment.
Novelty suppressed feeding
Animals were food deprived for 24 h before being placed in the
corner of the OF arena (MedAssociates Inc) and left to explore it
for 10min. A single pellet of food was placed in the center of the
novel environment and the latency the animal took to leave the
corner and feed was recorded. Upon reaching and start eating the
pellet the animal was placed back in the home cage, where it was
allowed to eat pre-weighted food. Food intake was recorded after
5, 15, and 30min, as a measure of appetite drive.
GOLGI-COX STAINING
One week after completion of the behavioral tests mice
(5 Nenf+/+ and 5 Nenf−/−) were transcardialy perfused with
0.9% saline under deep anesthesia and brains were removed
for Golgi-Cox staining (Gibbs et al., 1998). Briefly, brains were
immersed in Golgi-Cox solution (a 1:1 solution of 5% potassium
dichromate (Merck, Darmstadt, Germany) and 5% mercuric
chloride (Merck) diluted 4:10 with 5% potassium chromate
(Merck) for 14 d; then transferred to 30% sucrose isolution
in 0.5% sodium azide where they were kept until process-
ing. Coronal vibrotome 200µm thick sections were collected in
6% sucrose and blotted dry onto clean, gelatin-coated micro-
scope slides, alkalinized in 18.7% ammonia, developed in Dektol
(Kodak, Linda-a-Velha, Portugal), fixed, dehydrated through a
graded series of ethanol, cleared in xylene, mounted with entellan
and coverslipped.
DENDRITIC TREE ANALYSIS
Basolateral amygdala (BLa) pyramidal neurons, anterior medial
bed nucleus of the stria terminalis (amBNST), lateral dorsal
bed nucleus of the stria terminalis (ldBNST) bipolar neurons,
ventral and dorsal dentate gyrus (DG) granular and ventral CA1
pyramidal-neurons of the hippocampus were chosen randomly,
3 per section; regional boundaries were defined as previously
outlined (Dong et al., 2001; Paxinos and Franklin, 2001). The
criteria to choose perfect Golgi impregnated neurons were the
same as described previously (Uylings et al., 1986): (1) dendritic
branches were not incomplete, broken or non-impregnated;
(2) dendrites did not show overlap with other branches; (3)
neurons were visually well-isolated. Twenty five to 30 neurons per
experimental group were studied, i.e., 5–6 neurons per animal
were analyzed for each of the 5 animals in the experimental
groups. For each selected neuron, all branches of the dendritic
tree were reconstructed at 600× magnification using a motorized
microscope (BX51, Olympus), with oil objectives attached to a
camera (Microbrigthfield Bioscience, Madgedurg, Germany) and
using the Neurolucida software (Microbrightfield). Dendritical
parameters analyzed were the total dendritic length and 3D
version of the Sholl analysis (Sholl, 1956); where, the number of
dendritical intersections with concentric spheres positioned at
20µm intervals from the neurons soma was counted using the
NeuroExplorer software (MicroBrightField).
NEUROCHEMICAL ANALYSIS
Monoamines’ levels were measured using high performance liq-
uid chromatography with electrochemical detection (HPLC-ED).
Naive 3 months old male mice were killed by decapitation (10
Nenf+/+ and 8 Nenf−/−). Skulls were snap frozen in liquid nitro-
gen to avoid degradation during macrodissection. Brains were
carefully dissected for ventral hippocampus, amygdala, BNST.
Dissection was performed on ice with the help of a stereomicro-
scope.
Dissected tissues were weighed and then homogenized and
deproteinized in 100µL of 0.2N perchloric acid solution
(Applichem, Darmstadt, Germany) containing 7.9mM Na2S2O5
and 1.3mM Na2EDTA (Riedel-de Haën AG, Seelze, Germany),
centrifuged at 20000 g for 45min at 4◦C and the supernatant was
stored at −80◦C until analysis.
The analysis was performed using a GBC LC1150 HPLC
pump (GBC Scientific Equipment, Braeside, Victoria, Australia)
coupled with a BAS-LC4C (Bioanalytical Systems Inc., USA)
electrochemical detector, as previously described (Kokras et al.,
2009). The working electrode of the electrochemical detec-
tor was set at +800mV. In all samples reverse phase ion
pairing chromatography was used to assay dopamine (DA)
and its metabolites 3,4 dihydroxyphenylacetate (DOPAC) and
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homovanillic acid (HVA), serotonin (5HT) and its metabolite
5-hydroxyindoleatic (5HIAA) and norepinephrine (NE). The
mobile phase consisted of a 50mM phosphate buffer regulated at
pH 3.0, containing 5-octylsulfate sodium salt at a concentration
of 300mg/L as the ion pairing reagent and Na2EDTA at a con-
centration of 20mg/L (Riedel-de Haën AG); acetonitrile (Merck,
Darmstadt, Germany) was added at a 9% concentration. The
reference standards were prepared in 0.2N perchloric acid solu-
tion containing 7.9mM Na2S2O5 and 1.3mM Na2EDTA. The
column used was an Aquasil C18 HPLC Column, 100 × 1mm,
5µm Particle Size (Thermo Electron, UK). Samples were quan-
tified by comparison of the area under the curve against known
external reference standards using a PC compatible HPLC soft-
ware package (Chromatography Station for Windows ver.17 Data
Apex Ltd). The limit of detection was 1 pg/20µL (of injection
volume). In addition to the assay of 5-HT and 5-HIAA tissue
levels, the 5-HT turnover rate was also calculated, separately for
each chromatograph, as the ratio of 5-HIAA/5-HT. Similarly, the
ratios of DOPAC/DA and HVA/DA were calculated as an index
of DA turnover rates. Turnover rates estimate the serotonergic
and dopaminergic activities better than individual neurotrans-
mitter and metabolite tissue levels as they reflect 5-HT and DA
release and/or metabolic activity as described elsewhere (Dalla
et al., 2008; Kokras et al., 2009; Mikail et al., 2012).
STATISTICAL ANALYSIS
All values presented are expressed as the mean ± SEM and sig-
nificance was verified by using the Mann–Whitney test for inde-
pendent samples for all behavior, dendritic length, sholl analysis
and neurochemical data. Differences were considered significant
when p < 0.05.
RESULTS
ABLATION OF NEUDESIN INDUCES AN ANXIOUS-LIKE PHENOTYPE IN
ADULT MICE
Despite the described neuronal expression profile of neudesin in
the adult brain, no information is available on the relevance of
this protein for the central nervous system (CNS) functioning. To
tackle this gap we performed a wide behavioral characterization
of neudesin-null mice.
From the behavioral analyses performed we observed that the
ablation of neudesin induces a striking anxious-like phenotype
as revealed by a series of tests that specifically assess anxiety-like
behavior. We first used the EPM to analyze anxiety-like behavior
and found that the percentage of time neudesin-null mice spent
in the open arms (22%) was significantly lower than that of
controls (37%) (Figure 1A) and, conversely, more time was
spent in the closed arms (67%) when compared to controls
(50%) (p < 0.05). Of relevance, the number of entries in the
closed arms (Nenf+/+ = 10.8 ± 1.5 and Nenf−/− = 8.5 ± 1.8 s)
did not significantly differ between the groups, indicating that
the exploratory activity is preserved in neudesin-null mice.
This anxious phenotype was further confirmed in other con-
textual behavioral paradigms, namely the LDB and the NSF.
In the LDB test neudesin-null male mice spent more time in
the dark zone (396.6 ± 27.5 s) when compared to controls
(296.1 ± 25.0 s) (p < 0.05) and significantly less time in the light
FIGURE 1 | Neudesin-null mice (Nenf−/−) display an anxious-like
behavior in contextual paradigms. (A) Nenf−/− mice spend significantly
less time exploring the open arms of the EPM than control mice (Nenf+/+).
(B) The LDB test shows that Nenf−/− mice spend more time in the dark
zone than in the light zone. (C) Also, in the NSF Nenf−/− mice take longer
to feed in the novel environment when compared with Nenf+/+. (D) The AS
test shows that Nenf−/− mice have a similar startle response to higher
intensities of sound not reflecting an anxious like behavior in this anxiety
dimension. (E) In the OF no differences were observed between Nenf−/−
and Nenf+/+ in the total distance traveled in the arena. (F) Performance in
the FST, which assessed learned helplessness behavior does not reveal
differences between the two groups. (G) Cognition, as assessed using the
MWM test, is identical between groups, as revealed by the time taken to
learn the platform position. (H) The % of distance swum in the new
quadrant in the reversal trials of the MWM test did not reveal any
differences between groups. Data are presented as mean ± SEM.
∗p < 0.05. OA, open arms; CA, closed arms; H, hub; DZ, dark zone; LZ,
light zone?
zone (Nenf+/+ = 303.4 ± 24.9 vs. Nenf−/− = 202.8 ± 27.5 s)
(p < 0.05) (Figure 1B); importantly there were no differences
regarding the total distance travelled (data not shown). In the
NSF test animals have an extra motivational cue—they are fas-
tened for 24 h—so when they are placed in a novel environment,
the latency to feed is a measurement of anxiety. In this test we
observed that neudesin-null mice displayed increased latency
time to eat in the OF arena (416.8 ± 63.6 s) when compared to
controls (253.8 ± 35.9 s) (p < 0.05) (Figure 1C). The previously
described tests are based on conflicts between the animal’s innate
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exploratory/feeding behavior and its aversion for open brightly
lit spaces. These are often considered tests for state anxiety and
are dependent on cortical processing. On the other hand, the
AS test is based on a reflex response to aversive stimuli that
tests for a different dimension of anxiety, a more generalized
and innate response—trait anxiety. Therefore, a more anxious
animal will respond with a bigger startle at higher intensities
of sound. Interestingly, the AS test failed to show an anxious
like behavior in neudesin-null mice (Figure 1D), even at the
higher intensities of sound (120 dB) (Nenf+/+ = 22.37 ± 3.26
vs. Nenf−/− = 23.45 ± 3.29ms) (Figure 1D).
Regarding other behavioral traits, neudesin-null mice did not
reveal any phenotype. The OF arena was used to assess loco-
motor activity. The analysis revealed that neudesin-null mice
did not display motor impairments, when compared to control
animals (Figure 1E). We used the FST to measure helplessness
behavior, a behavioral dimension relevant for depression. In the
FST (Figure 1F) both controls and neudesin-null animals spent
a similar amount of time immobile (Nenf+/+ = 229 ± 5 vs.
Nenf−/− = 225 ± 8 s), thus indicating that neudesin-null mice
do not display a depressive-like behavioral phenotype. Cognition,
specifically spatial reference memory, was analyzed in the MWM.
Both neudesin-null and control mice learned the position of the
hidden platform as they similarly decreased the latency of time
required to perform the task, indicating an absence of cognitive
impairment (Figure 1G); this was further confirmed in the probe
test (data not shown). Regarding performance in the reverse
learning task of the MWM, the percentage of distance swum in
the new quadrant by neudesin-null mice was similar to that of
control mice (Figure 1H).
NEUDESIN-NULL ADULT MALE MICE HAVE ALTERED NEURONAL
MORPHOLOGY
Neuronal morphology, dendrite formation and the establishment
of synaptic contacts are dependent of trophic support. Due to the
potential role of neudesin as a neurotrophic factor we studied the
3D-morphology of neurons in neudesin-null mice. In light of the
anxiety-like phenotype described before, we focused the analysis
in brain regions implicated in the modulation of this behavioral
trait, namely the ventral hippocampus, the amygdala (BLa nuclei)
and the BNST. When compared to control mice, neudesin-null
mice presented shorter dendritic length of ventral hippocampal
DG granular neurons (Nenf+/+ = 741.8 ± 32.8 vs. Nenf−/− =
463.9 ± 83.3µm) (p < 0.05) (Figure 2A left panel). Sholl analy-
sis also revealed fewer intersections of the dendritic tree (with the
imaginary spheres) at distances between 60 and 120µm from the
soma in neudesin-null mice (p < 0.001) (Figure 2A right panel).
Nevertheless, in ventral hippocampal CA1 pyramidal-like neu-
rons no difference was found between control and neudesin-null
mice in dendritic length or dendritic arborization, both for the
basal and for the apical dendrites (Figure 2B). Noteworthy the
differences found for ventral hippocampal DG neurons were not
observed in the dorsal DG granular neurons (Nenf+/+ = 644.7 ±
29.3 vs. Nenf−/− = 606.3 ± 39.9µm). Regarding the BNST, two
different divisions were analyzed, the anterior medial BNST
(amBNST) and the lateral dorsal BNST (ldBNST); neudesin-null
mice had a statistically significant reduction in dendritic length
in the anterior medial (Nenf+/+ = 584.8 ± 36.7 vs. Nenf−/− =
412.6 ± 14.7µm) (Figure 2C left panel), but no differences in the
lateral dorsal division (Nenf+/+ = 628.7 ± 64.5 vs. Nenf−/− =
485.2 ± 34.1µm), as well as no differences regarding dendritic
arborization of neurons in both BNST divisions. Finally, the mor-
phology of pyramidal-like neurons of the BLa was analyzed and
no differences were observed between control and neudesin-null
mice (Figure 2D).
NEUROTRANSMITTER ACTIVITY PROFILE IN ANXIETY RELATED
REGIONS
Given the behavioral and structural alterations found in
neudesin-null mice we next characterized the monoaminergic
profile (major findings presented Table 1 for complete data) of
several anxiety-related brain regions (amygdala, BNST, ventral
hippocampus). We observed a reduction of DA levels in the ven-
tral hippocampus of neudesin-null animals (p < 0.05) (Table 1),
which was accompanied by an elevated dopaminergic turnover of
HVA/DA (p < 0.05) (Table 1). Regarding the amygdala, there was
a trend for a reduction in DA, DOPAC, and NE levels (Table 1);
in the BNST no alterations were observed in monoamines levels
or turnover (Table 1).
Regarding serotonin, a significant reduction of the serotonin
metabolite 5HIAA (p < 0.05) (Table 1) was seen in the ven-
tral hippocampus, but this difference did not translate into any
alterations regarding serotonin turnover. An ∼40–50% reduc-
tion in the levels of both 5HT and 5HIAA in neudesin-null mice
was also observed in the amygdala but these differences did not
reach statistical significance for both metabolites. In the BNST
no differences were observed for 5HT metabolites and respective
turnover rates.
DISCUSSION
This work provides the first in vivo demonstration of the relevance
of the neurotrophic factor neudesin for CNS normal function. In
the absence of neudesin, mice display a contextual anxious like
phenotype that is accompanied by impairment in the dopamin-
ergic activity of the ventral hippocampus, where the dendritic
arborization in granular neurons branching is impoverished; in
addition, they also present a dendritic atrophy in the amBNST
nucleus.
We first addressed the role of neudesin by exploring the
behavioral consequences of its ablation. Of the several behav-
ioral dimensions assessed, only anxiety-related phenotypes were
clearly affected by the absence of neudesin, as demonstrated by
the shorter time spent in the open arms of the EPM and in the
light zone of the LDB and the higher latency to eat in the NSF
test. Interestingly, no deficits were found in the AS, which reveals
that the increased anxiety occurs specifically in contextual conflict
paradigms, described to involve modulation by different neu-
ronal circuits (Koch and Schnitzler, 1997). Anxiety in the presence
of contextual anxiogenic environments, such as those observed
here, is shown to be mediated by the BNST (Ventura-Silva et al.,
2012) under the modulation of different cortical regions namely
the hippocampus and the prefrontal cortex (Ventura-Silva et al.,
2013). The BNST is closely involved in stress and in the HPA
axis-dependent modulation of emotional behaviors (Herman and
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FIGURE 2 | Three-dimensional morphometric analysis of Golgi-Cox
impregnated neurons of the ventral hippocampus, BNST and
amygdala. Nenf−/− mice have shorter dendrites than controls in the
dentate gyrus (DG) of the ventral hippocampus (A, left panel) as well
as less intersections between dendrites (A, right panel). These
differences in dendrite morphology and neuron arborization are not
observed for the hippocampal CA1 region (B, left and right panel,
respectively). Neudesin-null mice have shorter dendritic length in the
anterior medial division of the BNST (amBNST) and no differences in
the number of intersections in the sholl analysis (C, left and right
panel, respectively). Analysis of the basolateral nucleus of the amygdala
(BLa) revealed no differences concerning dendritic length or arborization
(D, left and right panels, respectively). The middle panels correspond to
a representative 3D reconstructed neuron from each region analyzed
from both Nenf+/+ (left) and Nenf−/− (right). Data are presented as
mean ± SEM. ∗p < 0.05.
Cullinan, 1997). It has been reported that anxiety triggered by
different stress-inducing paradigms is related to hypertrophy of
the amBNST neurons (Pego et al., 2008; Oliveira et al., 2012).
Surprisingly, however, neudesin-null mice display shorter den-
drites in the amBNST, which suggests this might be a stress-
specific effect and that other factors beyond the pure structure
of these neurons might underlie the behavioral changes displayed
by neudesin-null mice.
Interestingly, the same holds true for the ventral hippocam-
pus, where we also found dendritic atrophy, specifically in granule
cells. The role of the ventral hippocampus in anxiety has been a
matter of debate, with some studies showing that an increased
activity in this brain region is related with increased emotionality
(McHugh et al., 2004, 2011), while others studies do not confirm
this association (Marrocco et al., 2012). Recently, however, the
activity of ventral granule cells has been specifically implicated
in anxiety behavior. Using optogenetics tools to activate and to
inhibit DG granular cells in the ventral hippocampus, Fournier
et al saw that elevating activity in this area suppresses anxiety in
the EPM (Fournier and Duman, 2013). The present results seem
to support the later study, in as much as we show that neudesin-
null mice present an impoverished arborization in granule cells
of the ventral hippocampus. Noteworthy, this later effect is spe-
cific to the ventral hippocampus since we found no differences
between control and neudesin-null mice in the arborization of
dorsal DG granular cells. Given the recently shown role of dorsal
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Table 1 | Levels of monoamines in brain areas of littermate control
(Nenf+/+) and neudesin-null (Nenf−/−) mice.
Nenf+/+ Nenf−/−
VENTRAL HIPPOCAMPUS
NE 1.49±0.22 1.06±0.31
DA 0.49±0.10 0.27±0.09*
DOPAC 0.43±0.15 0.35±0.15
HVA 0.32±0.06 0.27±0.10
DOPAC/DA 0.78±0.13 1.17±0.22
HVA/DA 0.61±0.07 1.02±0.08**
5HT 8.69±1.51 5.21±1.31
5HIAA 10.59±2.40 6.28±1.92*
5HIAA/5HT 0.94±0.09 1.08±0.09
BED NUCLEUS OF THE STRIA TERMINALIS
NE 9.44±1.49 13.58±4.33
DA 6.77±1.51 9.54±3.85
DOPAC 8.32±2.57 9.89±3.95
HVA 5.38±1.15 6.52±1.85
DOPAC/DA 0.96±0.10 1.33±0.20
HVA/DA 0.72±0.10 1.16±0.21
5HT 13.12±3.69 16.12±4.88
5HIAA 6.72±1.41 9.80±2.35
5HIAA/5HT 0.60±0.06 0.72±0.07
AMYGDALA
NE 2.50±0.69 1.57±0.41
DA 6.76±1.56 3.00±1.09
DOPAC 7.54±2.40 3.16±0.86
HVA 3.33±1.04 1.38±0.35
DOPAC/DA 0.99±0.14 1.38±0.45
HVA/DA 0.50±0.07 0.56±0.12
5HT 15.08±3.31 6.50±0.98
5HIAA 10.15±2.81 5.97±1.58
5HIAA/5HT 0.64±0.07 0.91±0.21
Levels of catecholamines and monoamines are in µg/g tissue and expressed as
means ± S.E.M. *p < 0.05 and **p < 0.01.
DG cells in the modulation of learning (Kheirbek et al., 2013),
this result is in accordance with the absence of a cognitive pheno-
type in neudesin-null mice. This specific alteration in the atrophy
of DG granule cells along the dorsal-ventral axis in the absence of
neudesin is of relevance and deserves further investigation.
Going further into the molecular levels, we next studied
the monoaminergic profile of anxiety-related brain regions.
Interestingly, the absence of neudesin is associated with low lev-
els of DA and increased HVA/DA turnover ratio in the ventral
hippocampus. Importantly, DA levels are described to be higher
in the ventral than in the dorsal hippocampus (Eisenhofer et al.,
2004) and DA is known to play a crucial role in modulating plas-
ticity in the ventral portion of the hippocampus (Belujon and
Grace, 2011). In addition, dopamine 1 receptor (D1) is highly
expressed in the dendrites of the granular cells of the ventral
DG (Mansour et al., 1992), and dopamine release from project-
ing ventral tegmental area neurons impacts on the modulation
of synaptic plasticity and synapse strenght in this brain region
(Hamilton et al., 2010). Whether decreased DA release in the
ventral hippocampus, as observed in neudesin-null mice, con-
tributes to the dendritic atrophy in ventral DG granular neurons
is unknown. Nevertheless, the role of dopamine in anxiety is
also endowed in controversy: while pioneer studies with systemic
apomorphine (a D1/D2 agonist) administration were shown to
decrease anxiety (Hjorth et al., 1986), more recent studies using
specific administration of this drug in the ventral hippocampus
increased anxiety in the EPM (Zarrindast et al., 2010). Regarding
the levels of 5HT, it is of notice that the ventral hippocampus of
neudesin-null mice displays a decrease (although not significant)
of 40% in the levels of 5HT and a sharp reduction in the levels
of its derived metabolite 5HIAA. This is of relevance since selec-
tive knock-down of auto 5HT-1A receptors in the raphe nuclei
of mice results in a direct increase of anxiety levels in contextual
paradigms, and in a concomitant decrease in the extracellular lev-
els of 5HT in the ventral hippocampus (Richardson-Jones et al.,
2011). Thus, the alteration in serotonergic metabolites observed
in the ventral hippocampus may contribute to the anxiety state
observed in neudesin-null mice, in accordance to previous studies
in stressed animals (Dalla et al., 2008). Also interesting, although
not significant, is the reduction in the 5HT levels in the amygdala
of neudesin-null mice. This may be of relevance when considering
the fundamental role of 5HT as a player in the crosstalk between
amygdala and the ventral hippocampus in themodulation of anx-
iety behavior (Asan et al., 2013). Overall, these results further
highlight a possible role for neudesin in the establishment and/or
maintenance of hippocampal circuitry and in the modulation of
contextual anxiety-behavior.
Both during embryonic and postnatal brain development sev-
eral external signals including neurotrophic factors, neurotrans-
mitters and hormones are involved in the genesis and maturation
of new neurons and in their integration into functional circuitries
(Abrous et al., 2005). One of the unique roles previously ascribed
to neudesin, as shown in vitro, is its neurotrophic activity (Kimura
et al., 2005, 2006). Thus, it is plausible that the herein described
functional alterations in neuronal arborization result from the
absence of neurotrophic support conveyed by neudesin. On the
other hand, neudesin structure displays a heme and/or steroid-
binding site (Kimura et al., 2005), which seems necessary for its
function (Kimura et al., 2008). Free heme is a powerful oxida-
tive stressor (Jeney et al., 2002; Craven et al., 2007; Abraham and
Kappas, 2008) and under physiological conditions it is bound to
extracellular heme binding proteins such as Nenf. Thus, we can-
not discard the possibility that the deleterious effects of free heme
due to the absence of neudesin might have implications in the
maintenance of neurons as previously suggested (Burmester and
Hankeln, 2004).
The data presented in this study suggest that neudesin modu-
lates anxiety behavior mainly through the DG ventral hippocam-
pus and altered dopaminergic activity. Thus, the neurotrophic
action described previously for neudesin per ser, or in association
with its ligands, might be of therapeutical and/or pharmacolog-
ical potential in anxiety-related disorders. The modulatory role
of neudesin in anxiety might be associated with its putative neu-
rotrophic role but why this effect is specific for the anxiety circuits
is still to be determined. Nevertheless, since the mouse model
used in this study is a constitutive knock-out of the Nenf gene, we
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cannot exclude potential developmental determinants (Stevens
et al., 2010) resulting from the absence of neudesin in adult
anxiety circuits, which should next be investigated.
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